Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Journal of Virology|April 1, 1995
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitorA K Patick, R Rose, J Greytok, et al.The Journal of Infectious Diseases|November 1, 1994
Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapyP F Lin, H Samanta, R E Rose, et al.Journal of Medicinal Chemistry|April 10, 1999
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimeticsP S Dragovich, T J Prins, R Zhou, et al.Journal of Medicinal Chemistry|December 20, 1996
Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C proteaseS E Webber, J Tikhe, S T Worland, et al.Antimicrobial Agents and Chemotherapy|October 3, 1999
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C proteaseA K Patick, S L Binford, M A Brothers, et al.Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acidsP S Dragovich, S E Webber, T J Prins, et al.Journal of Medicinal Chemistry|May 5, 2000
Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluationS H Reich, T Johnson, M B Wallace, et al.Journal of Medicinal Chemistry|July 21, 1998
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacementsS E Webber, K Okano, T L Little, et al.Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitorsS E Webber, J T Marakovits, P S Dragovich, et al.Bioorganic & Medicinal Chemistry Letters|January 15, 2000
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsP S Dragovich, R Zhou, S E Webber, et al.Pageof 5